Paul Sagan

Paul has more than 30 years of experience in investor relations, corporate communications, and integrated communications for both publicly traded companies and emerging private entities. He has helped develop investor communications strategies for more than $2.5 billion in public equity, venture, and convertible debt offerings.

His practice focus has been primarily in the life science/biotech and medical device fields where he has advised more than 50 firms from venture-backed startups to multinational corporations. He is instrumental in the agency’s investor research and analytics capabilities, as well as investor identification and targeting outreach.

A five-time winner of the PR Club’s Bell Ringer award, he also has extensive experience in media relations and marketing communications and is skilled at communicating complex information for his life science clients to both the investment community and to the general public. He has secured media coverage for his clients in the Wall Street Journal, Barron’s, The New York Times, The Washington Post, CNBC, and National Public Radio; as well as The Economist, U.S. News & World Report, The Boston Globe, Dow Jones, and The Associated Press.